12:00 AM
 | 
Aug 25, 2008
 |  BC Week In Review  |  Clinical News  |  Clinical Results

KRP-104: Phase Ib data

Top-line data from an open-label, U.S. Phase Ib trial in 28 patients with Type II diabetes showed that KRP-104 was...

Read the full 79 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >